Whythawk PhaseZero reports offer rapid, high-level comparative country insight. Our reports combine quantitative and qualitative content with striking data visualisation. To assist comprehension, chart elements - called sparklines - are integrated throughout the report to allow concise and immediate comparisons of all reported data.
Charts and data are presented relative to a benchmark of leading emerging market investment destinations. All content is comprehensively referenced with online links embedded into the report for immediate access to source documentation.
France has been analysed according to the following segments:
1. Demography: Population, Health and Education
2. Economy: Market Opportunity and Investment Environment
3. Infrastructure: Telecommunications, Energy, Access and Rights
4. State: Governance, Law and Stability
5. Structure: Aid, Enterprise and State Expenditure
6. Healthcare: Morbidity, Mortality & Treatment
A flavour of major economic opportunities and risks highlighted in the PhaseZero France report:
- A payoff for the outgoing boss of car parts supplier, Valeo, while the company is receiving state aid and
preparing to cut jobs has stoked France's long suspicion of business and the stock market. The latest scandal broke in March 2009 when it emerged that Thierry Morin, the outgoing chief executive of Valeo, was to take a 'golden parachute' of $4.36 million.
- France's national railway in February 2010 awarded Canadian rail manufacturer Bombardier a contract that could eventually be worth $10.7 billion. The initial order for 80 regional trains and options for 49 more could exceed $1.4 billion. The trains will increase the French railway's capacity by 20.0 percent while using 15.0 percent less energy.
- In 2008, Nicholas Sarkozy guaranteed $640.0 million in state backing for joint EDF-Renault electric car recharging network. Automaker Renault and French utility EDF announced a major new partnership designed to build a nationwide electric car recharging network in France by 2011.
- France is the fourth largest medical device market in the world, ranking behind the US, Japan, and Germany. New measures have recently been taken to control spending on medical devices similar to those already in force for pharmaceuticals. For this reason, the medical market is only likely to see moderate growth, rising from $8.8 billion in 2010 to $9.8 billion by 2015.
READ MORE >
France Market Insight Contents
Introduction to France
The Bue Curve and Emerging Market Analysis
Methodology: Bue Analysis
Comparative GDP Forecast, and Exchange Rate Base Year and Value
Segment 1: Demography
Segment 2: Economy
Segment 3: Infrastructure
Segment 4: State
Segment 5: Structure
Segment 6: Healthcare
Bue Analysis Conclusions
References: Data Sources
References: Content Sources
France Market Insight Figures
Key Country Rankings (France), 2010
Bue Curve - Summary of Results (France), 2010
Gross domestic product, current prices in US dollars (France), 2010
Euro Vs. US Dollar, 2000 - 2009
Key Population and Education Indicators (France), 2010
Key Health Indicators (France), 2010
Key Market Opportunity Indicators (France), 2010
Key Investment Environment Indicators (France), 2010
Key Telecommunications Indicators (France), 2010
Key Energy Indicators (France), 2010
Key Governance and Legal Indicators (France), 2010
Key Stability Indicators (France), 2010
Key State Ease of Business Indicators (France), 2010
Key Aid and Enterprise Indicators (France), 2010
Key Mortality and Morbidity Indicators (France), 2010
Key Treatment Indicators (France), 2010
Final Table of Bue Scores (France), 2010
Note: Product cover images may vary from those shown